News and Events

March 31, 2021 – NEWS

Indivumed Launches Spinoff Ix Therapeutics

Read More

March 18, 2021 – PRESS

Indivumed Announces Expansion Into Drug Development, Formation of Ix Therapeutics

Read More

January 26, 2021 – NEWS

Indivumed appoints Roald Forsberg as new Chief Business Officer

Read More

January 05, 2021 – NEWS

A retrospective and outlook

Read More

Research Publications

Product Information

Biospecimen Products

To meet all your needs in cancer research and drug development we offer you a broad spectrum of high-quality biospecimen samples including clinical data.

Applications and CRO Services

To further support your efforts in personalized oncology we offer you an holistic range of clinical, laboratory, and research services.

ISO-Certified Expertise

Indivumed GmbH’s long-standing expertise with its business units IndivuServ and IndivuType is ISO 9001:2015-certified and includes the collection of biological samples and clinical data (Biobank), research service in the form of immunohistochemistry, analysis of signaling proteins, drug testing, establishment of primary cell cultures and molecular biology, bioinformatic and biomedical data analysis. 

Download the ISO-Certificate

Media

Discover more about Indivumed’s work and the future of personalized cancer medicine in the following lectures and videos.

Image

Partners

Global Clinical Network:
Prof. Jesus Garcia Foncillas - Hospital Universitario Fundacion Jimenez Diaz

Global Clinical Network:
Dr. Rafael López López - Hospital Clínico Universitario de Santiago

Global Clinical Network:
Dr. Xavier Matias-Guiu - Hospital Universitario Arnau de Vilanova Lleida

Global Clinical Network:
Prof. Gerry Melino - Hospital Tor Vergata Italy

Global Clinical Network:
Prof. Sun Young Rha - Severance Hospital Yonsei University Health System

Global Clinical Network:
Dr. Carlos Sampaio - Clinica AMO Brazil

Global Clinical Network:
Prof. Takayuki Yoshino – National Cancer Center Hospital East Japan

Cooperational Partnership:
Gnosis Data Analysis

Cooperational Partnership:
Biognosys AG

Scientific Lectures

22CEMIT Symposium: Overview and Perspectives for Translating Multi-omics into Clinical Utility in Solid Tumors. Speaker: Prof. Dr. Hartmut Juhl

Next In Personalized Medicine - Cancer-Phenotyping
Speaker: Hartmut K. Land, Ph.D., Prof. Dr. Hartmut Juhl

Personalized Oncology – Why Tissue Is the Issue When Characterizing Tumor Expression
Speaker: Dr. Bernd Gromoll, Prof. Dr. Hartmut Juhl

Opening Remarks and The Importance of Biobanking on Personalized Medicine
Speaker: Carolyn Compton

The Challlenge and Importance of Standardizing Pre-Analytical Variables in Surgical Pathology Specimens for Clinical Care and Translational Research. Speaker: David Hicks

How to Assess Tissue Quality to Improve Tissue Diagnostics
Speaker: Jim Crawford

The Future of Personalized Medicine in Oncology Has Begun
Speaker: John Marshall

IndivuType: Indivumed's Global Cancer Database Solution for Drug Development and Patient Care. Speaker: Hartmut Juhl